1 29 2024

Hi, This Week in Medicine, we will be discussingNew England Journal of MedicineDaratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease  Journal of  American Medical AssociationRape-Related Pregnancies in the 14 US States With Total Abortion Bans International Consensus Criteria for Pediatric Sepsis and Septic Shock  Functional Outcomes After Localized Prostate Cancer Treatment Cancer Diagnoses After Recent Weight Loss Recreational and Medical Cannabis Legalization and Opioid Prescriptions and Mortality  Opioid Prescribing Patterns After Imposition of Setting-Specific Limits on Prescription Duration  Annals of Internal MedicineCumulative Incidence of Thiazide-Induced Hyponatremia HIV Testing and Preexposure Prophylaxis Prescriptions Among U.S. Commercially Insured Transgender Men and Women, 2014 to 2021 Nature MedicineBritish Medical JournalEcological study estimating melanoma overdiagnosis in the USA using the lifetime risk method De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis LancetImetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial  JAMA CardiologyPolygenic Risk in Families With Spontaneous Coronary Artery Dissection